Delivery Order SPE2DB22D1202-SPE2DB25FVGN1
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,614.94 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.92 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a single procurement under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a $7,046.76 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $8,222.46 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp was awarded a $3,443.09 delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.22 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain, representing one of the specialized...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,551.43 on August 13, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used primarily for osteoarthritis joint pain...
- The Defense Logistics Agency awarded a delivery order valued at $8,866.94 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 25, 2025, with a completion date of August 26, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Monovisc is...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.75 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes (4 ml quantity) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain,...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.73 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML syringes (4 ML quantity) on August 12, 2025, with a completion date of August 13, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...